Target Price | $5.43 |
Price | $0.74 |
Potential |
633.69%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Clearside Biomedical, Inc. 2026 .
The average Clearside Biomedical, Inc. target price is $5.43.
This is
633.69%
register free of charge
$8.00
981.23%
register free of charge
$3.00
305.46%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Clearside Biomedical, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Clearside Biomedical, Inc. stock has an average upside potential 2026 of
633.69%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 1.66 | 3.97 |
79.83% | 139.16% | |
EBITDA Margin | -1,726.51% | -830.00% |
473.41% | 51.93% | |
Net Margin | -2,069.28% | -739.61% |
424.17% | 64.26% |
7 Analysts have issued a sales forecast Clearside Biomedical, Inc. 2025 . The average Clearside Biomedical, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Clearside Biomedical, Inc. 2025 . The average Clearside Biomedical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Clearside Biomedical, Inc. 2025 . The average Clearside Biomedical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.47 | -0.38 |
11.32% | 19.15% | |
P/E | negative | |
EV/Sales | 11.05 |
1 Analysts have issued a Clearside Biomedical, Inc. forecast for earnings per share. The average Clearside Biomedical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Clearside Biomedical, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 23 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | May 16 2025 |
Needham |
Locked
➜
Locked
|
Locked | May 15 2025 |
Needham |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 23 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
May 16 2025 |
Locked
Needham:
Locked
➜
Locked
|
May 15 2025 |
Locked
Needham:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.